Wrist Fractures Management With Arthroscopic Assistance Under Walant - Exploratory Study
WALANPOIGNE
1 other identifier
interventional
12
1 country
1
Brief Summary
Wrist articular fractures are more difficult to treat and rehabilitation takes longer. Furthermore, these joint fractures are frequently accompanied by ligament lesions of the carpal bones. For these reasons, it is strongly recommended to check the interior of the wrist joint. This check can be done with wrist arthroscopy. Therefore, fracture reduction can be improved, "step of stairs" can be eliminated under arthroscopic control and ligament rupture of carpal bones can be treated. WALANT anesthesia (Wide Awake Local Anesthesia No Tourniquet) designates a new local anesthesia technique. This technique which allows to maintain the arm or fingers mobility offers several significant advantages:
- Greater precision of the surgical procedure.
- A reduction in discomfort, risks and related adverse effects to anesthesia.
- Faster recovery. WALANT technique is very comfortable for patient and fits perfectly with principles of Enhanced Recovery in Surgery. In this context, this study is based on the hypothesis that it is possible to combine arthroscopy and the WALANT anesthesia technique for reducing wrist fractures
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 17, 2024
CompletedFirst Posted
Study publicly available on registry
April 23, 2024
CompletedStudy Start
First participant enrolled
November 6, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2027
November 24, 2025
November 1, 2025
2.6 years
April 17, 2024
November 18, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Failure percentage
A failure is defined by the impossibility of achieving the surgery under WALANT anesthesia. Practically, this translates either to stopping the procedure, either by intra-operative sedation (Protoxide nitrogen, deep hypnosis, general anesthesia) in emergency
Day 1
Secondary Outcomes (6)
Pain assessment
Day 1, 7 and 30
Patient experience
Day 1
Wrist mobility
Day 7 and 30
Functional characteristics of the wrist
Day 7 and 30
Functional characteristics of the wrist
Day 7 and 30
- +1 more secondary outcomes
Study Arms (1)
Walanpoigne
EXPERIMENTALThis arm will combine WALANT anesthesia WALANT with arthroscopy to reduce a joint fracture of the wrist
Interventions
Intervention will combine WALANT anesthesia with arthroscopy to reduce a joint fracture of the wrist
Eligibility Criteria
You may qualify if:
- Patient, male or female, aged ≥ 18 and \< 70 years
- Patient with a displaced articular fracture of the distal radius (unilateral wrist fracture)
- Patient treated on ambulatory way
- Patient affiliated to or beneficiary of a social security system
- French speaking patient, having signed informed consent
You may not qualify if:
- Patient with previous infection or wrist bone surgery
- Patient with multiple fractures or with bilateral wrist fractures
- Patient with associated fracture with the wrist fracture
- Patient with "pathological" bone
- Protected patient: adult under guardianship, curatorship or other protection legal, deprived of liberty by judicial or administrative decision
- Patient hospitalized without consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Clinique Les Franciscaines (Hôpital privé de Versailles)
Versailles, 78000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 17, 2024
First Posted
April 23, 2024
Study Start
November 6, 2024
Primary Completion (Estimated)
June 30, 2027
Study Completion (Estimated)
June 30, 2027
Last Updated
November 24, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share